Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Ibuprofen for Pain After Third Molar Extraction
NCT06704113Phase 4Not yet recruiting
- Sponsor
- Universidad Austral de Chile
- Start
- Dec 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of meloxicam in odontalgia, sponsored by Universidad Austral de Chile. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
meloxicam
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT06704113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06704113.